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Endothelin-1 in renal diseases. S. Naicker, R. Ramsaroop, P. Gathiram,
A. Nadar, J. Duursma, V Wilde, and I. Miyamori, Renal Unit, Addington
Hospital and Department of Medicine, University of Natal Medical School,
Durban, South Africa. High concentrations of immunoreactive endothelin
are present in the kidney. A variety of cell types (vascular endothelium,
renal tubular cells, and mesangial cells) are able to produce endothelin.
Aims: This study investigates the presence of endothelin- I in plasma and
renal tissue in renal disorders. Materials and methods: Frozen tissue from
15 renal biopsy specimens had immunohistochemistry performed on them
using rabbit anti-endothelin-1 and a PAP procedure. Plasma levels of
endothelin-l were assayed by an ELISA technique (Takeda Chemicals,
Japan). The diseases studied were primary mesangiocapillary glomerulo-
nephritis (MCGN-3), mesangial proliferative glomerulonephritis (MGN-
1), diffuse proliferative glomerulonephritis due to SLE (3), membranous
nephritis (MN-2), IgA nephritis (2), acute tubular necrosis (ATN-1), and
end-stage kidney disease (3). Results: There was intense staining of
glomerular capillary endothelial cells and mesangial cells in MCGN, SLE,
MGN and MN (1); intense staining of proximal tubular cells was seen in
MCGN and SLE. Weaker staining was present in IgA nephritis, ATN and
end-stage kidney disease and in endothelial cells of arterioles in all
specimens. The results were similar in hypertensive and normotensive
patients. Elevated plasma levels of endothelin-1 were present in patients
with SLE and MCGN (3.0—4.5 pg/mI). Endothelin-l levels in hemodialysis
patients (without SLE) ranged from 1.4—2.0 pg/mI. Conclusion: Enhanced
endothelin immunostaining was present in proliferative glomerulonephrit-
ides and SLE, with corresponding elevation of endothelin-1 in the plasma
of these patients.
Hepatitis B-associated glomerulonephritis. A clinicopathological study
in Namibian and South African children 1973—1993. W.D. Bates, A.J. van
Buuren, N. Muller, D.H. Geiger, and D.J. Rossouw, University of Stellenbosch
and Tygerberg Hospital, South Africa. Hepatitis B-associated glomerulone-
phritis is a common cause of nephrotic syndrome in children in endemic
areas. The aim of this study was to determine whether this disease in
children differs morphologically and clinically from the classical descrip-
tion of membranous nephropathy. The renal biopsies of 68 hepatitis-BsAg
positive children (55 boys and 13 girls) were studied by light and electron
microscopy as well as by immunological techniques. Twenty-seven of the
children were Namibian and 41 from South Africa. At presentation all thc
children showed features of nephrotic syndrome. All biopsies showed
some degree of mesangial deposits and proliferation, and 59 of the 67
(88%) with membranous features (subepithelial deposits) showed me-
sangial interposition. HBAg was demonstrated by monoclonal antibody
in 87% of the biopsies tested. The membranous subgroup with severe
mesangial interposition (23 cases) showed on biopsy (in comparison to the
other 44 membranous examples) significantly more mesangial and suben-
dothelial deposits, more advanced stages of membranous change, and
more sclerosis. This subgroup was significantly older than the rest and
hypertension was more frequent. All three of the membranous children
who developed chronic renal failure, including 2 who died, belonged to
this subgroup. The 41 Cape Province children showed an accumulated
remission rate of 30% at 2 years and 63% at 4 years. Of the 68 patients,
4 are known to have developed chronic renal failure and of these 3 have
died, one a Namibian child with a mesangiocapillary biopsy. Hepatitis
B-associated glomerular disease in children is a unique form of glomeru-
lonephritis which challenges and broadens the classical description, par-
ticularly of membranous nephropathy. Morphologically the glomeruli
show mesangial deposits and mesangial interposition, which indicate a
spectrum sharing features with mesangiocapillary glomerulonephritis.
Clinically, the marked male predominance, and a high spontaneous
remission rate of 60—90% over 4 years with a relatively low chronic renal
failure rate and/or mortality (5—10%), distinguish it from the classical
description of membranous glomerulonephritis.
A comparison of intravenous cyclophosphamide with oral cyclophos-
phamide for the treatment of lupus nephritis. Second interim report. MR.
Moosa, A. Halland, C. Edeistein, and W. Bates, Department of Medicine,
University of Stellenbosch, Renal Unit, Tygerberg Hospital, South Africa.
Background and aims: Lupus nephritis remains a potentially lethal
complication of SLE in our experience. The treatment of lupus nephritis
is a delicate balance between inadequate treatment with consequent renal
loss and the complications of aggressive immunosuppressive treatment.
We evaluated the clinical and pathological response to cyclophosphamide
(CMP) therapy given either orally (POCY) or intravenously (IVCY) for a
2 year period, together with low dose steroids. Methods: Patients with
newly diagnosed, biopsy proven, proliferative (WHO classes 111 + IV) and
membranous (WHO class V) lupus nephritis were randomized to receive
either POCY or IVCY. The dose of CMP was adjusted to maintain WCC
3—4000 ml. Clinical and biochemical parameters of response and adverse
effects to treatment were monitored. The renal biopsy was repeated in all
patients at 6 and 24 months. Results: Ten patients have thus far completed
the protocol; 5 received POCY and 5 IVCY. The patients improved
clinically and none suffered a flare-up of SLE. Biochemical and patholog-
ical data are shown below.
0 (IV/POCY) 6 (IV/POCY) 24 (IV/POCY)
Serum creatinine 132/105 89/82 133/87
DuProtein 1.0/2.3 0.1/0.9 0.5/0.7
C3 54/63 90/95 87/94
ESR 98/83 57/54 37/43
Activity index 6.2/6.8 2.2/3.2 2.6/3.0
Chronicity index 2.4/2.2 3.2/3.0 3.6/3.8
Results are presented as means. The improved results failed to reach
statistical significance, but trends were demonstrated. One patient died
during treatment and another required chronic dialysis after completion.
Both were receiving IVCY. Conclusion: Combined steroid-CMP treat-
ment is associated with marked improvement in lupus nephritis, with most
of the improvement occurring in the first 6 months of treatment. No clear
advantage of IVCY over POCY can yet be demonstrated. Serious
complications, though rare, can develop with treatment.
Direct and indirect tests of pore size and charge selectivity in nephrotic
syndrome. C. Ramjee, H.M. Coovadia, and M. Adhikari, Department of
Paediatrics and Child Health, Faculty of Medicine, University of Natal, Natal,
South Africa. Introduction: Disruptions of electrostatic charge barrier,
pore size and shape of the glomerular basement are responsible for
proteinuria in glomerular diseases. A similar negative charge is present on
the membranes of red blood cells (RBC) and platelets. Aim: To use direct
and indirect methods of membrane charge in the evaluation of protein-
uria. Methods: Fixed anionic sites were detected using Polyethyleneimine
(PET) on the glomerular basement membrane (GBM) and Alcian blue on
RBC membrane (ABRBC), respectively, in 33 children with nephrotic
syndrome (NS). Size selectivity of the GBM was measured indirectly by
fine analysis of urinary proteins using sodium dodecyl sulphate polyacryl-
amide gel electrophoresis (SDS PAGE) in 22 of these children. Main
results: Correlation between ABRBC and FE! was strongest (r = 0.8) in
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4 children with minimal change NS (MCNS); moderate (r = 0.31) in 10
children with focal glomeruloscierosis (FGS); and absent in 14 children
with HBs membranous nephropathy (MGN) and 5 with mesangioprolif-
erative glomerulonephritis (MPGN). ABRBC and PET were reduced in
the group as a whole compared to their controls (40.87 11.7 vs. 73.54
13.14, P < 0.05; 15.75 4.3 vs. 35.0 1.2, P < 0.005, respectively).
Excretion of glomerular proteins was restricted by size ( 80 kD) in
MCNS, but unrestricted ( 80 kD plus > 80 kD) in FGS, MGN and
MPGN. Conclusion: The main cause of proteinuria is likely to be
depletion of negative charge on the GBM in MCNS, and distortion of
capillaiy pore size in MGN and MPGN, with probable overlap of these
mechanisms in each disease, especially in FGS. Basement membrane
injury appears widespread in MCNS but confined to the kidney in MGN
and MPGN.
Treatment of hyperlipidemia with simvastatin (SV) and diet, versus
diet alone in idiopathic membranous nephropathy (IMN). B.L. Rayner, M
Byrne, and R. van Zyl-Smit, Renal Unit, Groote Schuur Hospital, Cape
Town, South Africa. The aim of this study was to determine whether SV
could safely lower cholesterol and retard progression of renal disease in
patients with IMN. Patients with biopsy proven IMN, cholesterol >6.1
mmol/liter, 24 hour protein >3.5 g/day and creatinine <200 smol/liter,
were alternatively assigned to treatment with SV and diet, or diet alone.
SV was begun at 10 mg/day and increased to a maximum dose of 40 mg
until the cholesterol was <5.1 mmol/liter. Seventeen patients have been
entered into the study. Mean follow-up was 18.8 months. Baseline data
were similar between the groups and SV was well tolerated. The mean
results for the first 18 months are shown llow with the diet alone group
shown first.
Time, months
0 6 12 18 21
Albumin, glliter 26.1
25.6
27.4
24
27.7
30.1
24.5
43.2
28
41.3
uProtein/Creatinine ratio 0.68
0.52
0.55
0.63
0.81
0.33
0.74
0.12
0.55
0.29
Cholesterol mmol/liter 10
10.5
10.0
7.9
9.6
6.8
9.7
5.8
10.5
5.9
The rate of decline in EDTA clearance was similar between the 2
groups (—1.19 ml/min/month in the SV group and —1.35 in the diet alone
group). In conclusion, this report suggests that SV can significantly lower
cholesterol in nephrotic patients with IMN, and may reduce proteinuria
and improve albumin levels.
Nephrotic syndrome in children at the H.F. Verwoerd hospital. G. van
Biljon, Department of Paediatrics, University of Pretoria, Pretoria, South
Africa. Sixty-seven children with nephrotic syndrome, presenting at the
H.F. Verwoerd Hospital between June 1986 and June 1994, were inves-
tigated. Forty-four (66%) children were white, 14 (21%) were black, 3
(4%) were Asian and 6 (9%) belonged to the colored population group.
Their ages ranged from 3 months to 12 years (mean 4.39 years); 74% of
the children with minimal change nephrotic syndrome (MCNS) on
histology were between 2—6 years old. Eleven children with clinical and
biochemical data, in keeping with MCNS, did not undergo renal biopsy.
They were presumed to have MCNS because of their previous or
subsequent satisfactory response to corticosteroids. Added to the group
with proven MCNS on histology, the total group constitutes only 56.7% of
all patients, which is much less than the 76.4% reported by the ISKDC.
Only two black children had MCNS, focal segmental glomerulosclerosis
(FSG) being the most common histological feature in the black children.
Eighty-one percent of children with MCNS responded well to corticoste-
roid treatment. Five children (18.5%) had early steroid resistance and five
(18.5%) developed late steroid resistance. Corticosteroid treatment was of
benefit to only one child with FSG. For the remaining ii children with
FSG, neither steroid nor cyclophosphamide treatment was of any benefit.
Only two children had membranous nephropathy, both associated with
HBs and HBe antigen carrier state. The incidence of this form of
nephrotic syndrome is much lower compared to the report of Gilbert and
Wiggelinkhuizen (16%) of Cape Town. Although congenital syphilis is still
commonly seen in our neonatal wards, luetic ncphrosis is rarely diagnosed.
Only one of our patients had luetic nephrosis which responded poorly to
penicillin treatment. Mortality in this group of 67 children was 3 (4.5%)
and was due to end-stage renal failure.
The significance of arterial hypertension in patients with lupus nephri-
tis (LN). I.P. Naiker, V. Chystal, I.G.H. Randeree, and YK Seedat,
Department of Medicine and Anatomical Pathology, University of Natal,
Durban, South Africa. This study aims to ascertain the prevalence of
hypertension in patients with LN and to investigate a possible association
between hypertension/renal vascular lesions and renal functional impair-
ment. A correlation will also be sought between histological class of LN
and hypertension. Methods: A retrospective analysis of 44 patients with a
diagnosis of LN (WHO classification) was performed. Hypertension was
graded as mild (diastolic 95—99 mm Hg), moderate (100—114), and severe
(>115). Impaired renal function (creatinine> 120 smol/liter) was graded
likewise. Histological class/presence of hypertensive renal vascular lesions
(HRVL) was based on pathology reports. Results: Seventeen patients
were hypertensive (group A); there was a prevalence of 38.6%. There were
also 27 normotensives (group B). Incidence of renal impairment in group
A versus B = 47% versus 18.5% (P = 0.043). Mean creatinine (.tmol/liter)
group A versus B = 283.4 versus 100.2 (P = 0.023). HRVL correlated with
renal impairment; incidence 63.6% versus 18.1% (P = 0.008) and creati-
nine 392.7 versus 97.0 (P = 0.012). Severe (proliferative) lupus histology
was more prevalent in group A, 70.5% versus 37.0% (P = 0.030). In group
A there was no correlation between severity of hypertension and either
renal function (r = 0.089) or histological class (r = 0.078). In conclusion,
our results show a dissociation of hypertension and LN with a prevalence
of only 38.6%. Hypertension and renal vascular lesions thereof correlated
well with renal impairment. Although proliferative lupus lesions were
more prevalent in hypertensives, there was no correlation between severity
of hypertension and histological class.
Comparison of SDS PAGE of urinary proteins with the conventional
method (selectivity index) for predicting steroid response in nephrotic
syndrome. G. Ramjee, H.M. Coovadia, and M. Adhikari, Department of
Paediatrics and Child Health, Faculty of Medicine, University of Natal,
Durban, South Africa. Introduction: Steroids are the mainstay of treatment
of nephrotic syndrome (NS) and have profoundly influenced management
and outcome. Renal biopsy in these diseases depicts changes which
correspond roughly to steroid responsiveness. However, biopsy is an
invasive procedure and is not always reliable to judge therapeutic behavior
to steroids. Accordingly, other predictive methods have been employed
and the most widely used since 1966 has been the selectivity index (SI)
measured by the ratio of IgG/transferrin in serum and urine. However, the
validity of SI has been questioned in a number of studies and this has led
to decrease in its use. We have recently shown that the qualitative
detection of a range of proteins by sodium dodecyl sulphate polyarylamide
gel electrophoresis (SDS PAGE) in the urine enables reliable prediction
of steroid responsiveness. Aim: We compared the predictive powers of SI
and SDS PAGE for steroid responsiveness in children with newly diag-
nosed minimal change nephrotic syndrome (MCNS) and focal glomeru-
losclerosis (FGS). Methods: There were 24 children with MCNS and 10
children with biopsy proven FGS. MCNS patients were those who
responded to conventional doses and duration of steroid therapy and had
a typical clinical course. All FGS patients were steroid resistant. SDS
PAGE was carried out on a second morning sample of urine. SI was
measured by nephelometry using simultaneously collected blood and urine
samples. Main results: The positive predictive value for steroid respon-
siveness by SDS PAGE was 100% and that by SI 70%. The negative
predictive value for steroid responsiveness was 100% by SDS PAGE and
40% by SI. Conclusion: SDS PAGE is a better predictor for steroid
responsiveness than SI in MCNS and FGS.
Glomerular basement membrane charge in early onset pre-eclampsia.
T. Naicker, I.G.H. Randeree, .1. Moodley, and YK Seedat, Electron Micro-
scope Unit, Natal Medical School, Durban, South Africa. Early onset
pre-eclampsia (EOPE) is a disorder characterized by severe proteinuria
and hypertension before 34 weeks of gestation. Anionic sites on the
glomerular basement membrane constitute an important barrier in ultra-
filtration. Evidence suggests that the enzymatic removal or the neutraliza-
tion of these sites results in proteinuria. A decrease in the number of
anionic sites has been demonstrated in minimal change nephropathy and
experimental aminonucleoside nephrosis. This prospective study was
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undertaken to evaluate the fixed anionic sites on the GBM of African
women with EOPE. Method: Staining of the anionic sites for electron
microscopy, using a cationic dye (polyethyleneimine) was performed on
kidney biopsies from 10 African patients with EOPE. Control specimens
were obtained from patients requiring partial nephrectomy. Results: PET
labelled anionic sites revealed electron dense particles within the lamina
rara externa (LRE), interna and lamina densa. The mean number of
anionic sites per 1000 nm of LRE in the EOPE group was 19.21 2.68
while that of the control group was 23.65 0.74 (P < 0.02). The
correlation coefficient of number of anionic sites versus severity of
proteinuria was —0.79. Conclusion: This study, the first in African women
with EOPE, demonstrates a significant reduction in glomerular basement
membrane charge. The strong correlation between the severity of protein-
uria and the loss of anionic sites in this study supports the hypothesis that
loss of glomerular charge may be one of the mechanisms responsible for
proteinuria in early onset pre-eclampsia.
Charge changes in early onset pre-eclampsia (EOPE). LG.H. Randeree,
G. Ramjee, T. Naicker, J. Moodley, YK Seedat, H.M. Coovadia, and M.
Adhikari, Departments of Medicine, Paediatrics, Electron Microscope Unit,
and the Medical Research Council Hypertensive Unit, Medical School,
University of Natal, Durban, South Africa. Introduction: Proteinuria in
pre-eclampsia may result from altered shape, size or charge selectivity of
the glomerular basement membrane (GBM). Charge selectivity is due to
the presence of anionic sites on surface membranes. Both erythrocytes and
the GBM possess similar anionic sites, allowing for indirect and direct
assessment of charge changes. Aim: To assess membrane negative charge
in EOPE using 2 cationic dyes, Alcian blue (AB) and polyethyleneimine
(PEI). Design: Prospective descriptive study. Subjects/methods: Indirect.
AB binding of eiythrocytes: 11 patients with EOPE (24 to 34 weeks
gestation) with 11 age, race and gestational age matched controls. Direct.
PET binding of the GBM: 10 patients with EOPE with 5 control specimens
viz, post-traumatic partial nephrectomy. Main outcome measures: Alter-
ation in AB binding of eiythrocytes and PET staining of GBM in EOPE
patients compared to controls. Results: Indirect AB technique: AB
binding was significantly decreased in the EOPE group 31.05 ng/106 cells
compared to controls 65.12 ngIlO6 cells (P < 0.0003). Direct PET
technique: ultrastructural morphometric evaluation of the labelled anionic
sites in the GBM showed a significant decrease in the laniina rara externa
of the EOPE group compared to controls [19.21 vs. 23.65 (P < 0.02)].
Conclusion: The decreased binding of cationic dyes at the level of the
erythrocytes and the GBM infers that a generalized disorder of membrane
negative charge may exist in EOPE.
Correlation between histological changes and urinary patterns of
proteinuria in early onset pre-eclampsia. G. Ramjee, I.G.H. Randeree, J.
Moodley, H.M. Coovadia, M. Adhikari, and YK Seedat, Department of
Paediatrics and Child Health, Faculty of Medicine, University of Natal,
Durban, South Africa. Introduction: Early onset pre-eclampsia (EOPE) is
associated with a high incidence of underlying renal disease. Patients are
generally not biopsied due to the invasive nature of the procedure.
Accordingly, nephropathies may go undetected and appropriate therapy
not instituted. This may lead to progression of underlying renal diseases.
A non-invasive technique for predicting glomerulonephritis (GN) is by the
use of sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS
PAGE). Glomerular proteinuria is indicated by excretion of high molec-
ular weight proteins and tubular proteinuria by excretion of low molecular
weight proteins. Aim: To correlate the urinary patterns of proteinuria with
histology in patients with EOPE and to evaluate the usefulness of this
technique in predicting the presence of GN. Method: Ten patients with
EOPE < 34 weeks gestation BP ( 140/90 mm Hg), proteinuria (> 4 g/24
hrs) and edema were studied by renal biopsy two weeks post-delivery.
Urine analysis by SDS PAGE was carried out 48 hours prior to biopsy.
Main results: Renal biopsy revealed underlying GN in 5 patients, and all
5 showed evidence of glomerular and tubular proteins. The other 5,
without histological evidence of GN, had glomerular proteins only.
Conclusion: SDS PAGE patterns of urinary proteins correlate well with
histology and may be a reliable test for identifying underlying GN in
EOPE.
Nuclear venography with technetium as a useful method for detection
of subclavian vein obstruction. A. Kobtyn, J. Kowalczylc and R.P. Clauss,
Transplant Unit, Ga-Rankuwa Hospital, Pretoria, South Africa. Subclavian
vein obstruction is a well-known complication of prolonged catheteriza-
tion of the subclavian vein for a temporary vascular access for hemodial-
ysis. Formation of arterio-venous (A-V) fistula in the upper extremity in
the presence of the subclavian vein obstruction results in a chronic
swelling of the upper limb and progressive disability. To avoid these
complications a routine screening of the renal failure patients with a
history of the subclavian vein catheterization with Muharkar dual lumen
catheter was carried Out prior to A-V access formation. Our method
selected for the investigation was the nuclear venography with GE
Starport gamma camera and intravenously injected technetium. The
following criteria for diagnosis of the subclavian vein stenosis or occlusion
were defined: (1) the mean transit time through the subclavian vein above
10 seconds; (2) reflux of isotope to the unilateral jugular vein; (3) presence
of a collateral circulation to the subclavian vein; (4) no flow of isotope
through the subclavian vein. The study was performed in 78 renal failure
patients. Seventy-two of them had undergone a unilateral or bilateral
catheterization of the subclavian vein in the past. The mean dwell time of
the catheter was 5 months. The subclavian vein stenosis or occlusion was
found in 53 patients (71%), which resulted in selection of the contralateral
upper extremity or the lower extremity for a permanent A-V access
formation. Conclusion: The nuclear venography is a useful, non-invasive
method for detection of the subclavian vein obstruction prior to A-V
access surgery in renal failure patients with a history of the subclavian vein
catheterization.
Coagulation profiles in chronic renal failure patients with subclavian
vein thrombosis caused by prolonged catheterization with Mahurkar dual
lumen catheters. J. Kowalczyk, A. Kobiyn, and GA. Culligan, Transplant
Unit and Haematology Department, Ga-Rankuwa Hospita4 Pretoria, South
Africa. Hemodialysis via the subclavian vein catheter was developed as a
temporary vascular assess for acute and chronic renal failure (CRF)
patients prior to establishing permanent vascular access. Thrombosis of
the subclavian vein after catheterization is a well-known late complication.
Twenty-eight CRF patients from the northern Transvaal, who were being
maintained on chronic hemodialysis at Ga-Rankuwa Hospital, were
selected for the study. All the patients developed unilateral or bilateral
subclavian vein stenosis following catheterization with Mahurkar dual
lumen catheters. The average dwell time of a catheter was 5 months (5
weeks to 9 months). The diagnosis of thrombosis of the subclavian vein
was established by both contrast venography and by technetium scanning
in all patients. We performed coagulation profiles on these patients with
the aim of establishing whether there was a hypercoagulable state that may
contribute to the development of venous thrombosis. The following
parameters were investigated: activated partial thromboplastin time
(APTT), antithrombin III (AT III), protein C, protein S, fibronogen (Fib),
and platelets. Samples of blood were taken prior to hemodialysis. The
preliminary results are as follows:
APTT 34.3 (23.8—45.8) N: 26—36 seconds
Fib 318.3 (210—500) N: 150—400 mg/dl
AT III 74.9 (50—122) N: 80—120%
Prot C 84.4 (42—109) N: 70—140%
Prot S
Plat
79.1 (30—120)
186 (88—276)
N: 60—140%
N: 150—400 >( 109/liter
Conclusions: The mean values of the studied parameters were all within
the normal range with the exception of AT III. A slightly lower level of
plasma AT III before hemodialysis is unlikely to be responsible for venous
thrombosis alone. No episodes of deep vein thrombosis (DVT) were seen.
The observed venous thromboses were restricted to the site of catheter-
ization only. This suggests an involvement of local factors initiating a
thrombotic process with, otherwise, normal coagulation state.
Acquired cystic kidney disease in heniodialysis patients. L. Sofianou, V.
Milkov, M. Rahme, and K. Missankova, Renal Unit, Department of Medi-
cine, University of the Witwatersrand, Johannesburg, South Africa. Twenty-
eight patients on chronic hemodialysis for more than 3 years were assessed
by sonography by 2 independent radiologists. Fourteen patients (5 females
and 9 males) showed acquired cystic kidney disease (ACKD). All patients
were asymptomatic-macroscopic hematuria, and severe flank pain was not
diagnosed. None of these patients required any intervention. Conclusion:
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Fifty percent of patients with end-stage renal disease on chronic hemodi-
alysis for more than 3 years present with ACKD.
Investigation of calcium oxalate crystallization in urine using flow
cytometry. A. Rodgers, B. Hibberd, and T Probyn, Chemistiy Department,
University of Cape Town, Rondebosch, South Africa. Aims: It is widely
recognized that an understanding of the mechanisms by which calcium
oxalate crystallizes in urine is an essential prerequisite for understanding
the morphogenisis of urinary calculi. Investigators have employed many
different techniques for measuring in vitro crystallization processes and
have identified nucleation, aggregation and growth as the key mechanisms.
Unfortunately, in many cases it is not clear precisely which of these three
mechanisms or, which combinations thereof, are being measured. In the
present study we undertook to characterize calcium oxalate crystallization
in urine by using flow cytometry. Methods: Twenty-four hour urine
collections were obtained from 10 healthy male subjects (ages 20—27
years). Crystallization was induced in each urine by administration of an
aqueous sodium oxalate load equivalent to the previously determined
metastable limit. Crystallization in each specimen was monitored for 120
minutes by measuring particle number, size, and shape using flow cytom-
etry. Results: Nucleation was identified as the sole crystallization mecha-
nism in 7 urines. In the remaining 3 specimens, nucleation was accompa-
nied by aggregation but not by growth. Conclusions: These results suggest
that nucleation is the key mechanism by which urinary stones are initiated
and that when crystallization occurs as a result of an increase in the
relative supersaturation of calcium oxalate, growth does not appear to be
important. The study has also demonstrated that meaningful results can be
obtained using flow cytometry, thereby providing the stone researcher with
a powerful tool for investigating urinary calcium oxalate crystallization
processes.
Hematuria after megadose protocol of ascorbic acid. B. Kroon, D. Auer,
and A. Rodgers, Chemistry Department, University of Cape Town, Ronde-
bosch, South Africa. Aims: While several studies have suggested that
vitamin C ingestion raises urinary oxalate, other studies have shown that
raised levels might be due to in vitro conversion of ascorbate to oxalate.
The present study was undertaken to examine the effect of vitamin C
ingestion on oxalate excretion and calcium oxalate crystalluria. Methods:
A 25 year old healthy male subject initially provided a 24 hour urine to
serve as a control. Thereafter he commenced a protocol in which he
ingested 9 g ascorbic acid per day for 8 days. Twenty-four hour urines were
collected on days 1 and 5 of the protocol and on days I and 6
post-cessation of vitamin C ingestion. Calcium oxalate metastable limits,
oxalate concentrations (in the presence and absence of EDTA), and
ascorbic acid concentrations were determined in all specimens. Filtered
crystals were examined by scanning electron microscopy (SEM). Results:
The vitamin C protocol was originally planned to last 9 days. However, on
the 8th day significant hematuria was detected and further vitamin C
ingestion was stopped immediately. During the protocol, metastable limits
decreased while the oxalate excretions, Tiselius risk indices, and calcium
oxalate relative supersaturations increased. SEM revealed the presence of
large crystal aggregates. Conclusions: The results indicate that vitamin C
ingestion induced calcium oxalate crystalluria in this subject and that the
passage of these crystals, as well as large aggregates thereof, caused
irritation and epithelial injury manifesting as hematuria. Although this
subject's response to vitamin C is probably rare, we believe that it should
be brought to the attention of stone researchers as high dosage ingestion
of ascorbic acid by such individuals could have very undesirable results.
Determination of functional renal reserve with radiopharmaceuticals.
G.P. Candy, iD. Esser, D.R. Fine, and AM. Meyers, Department of Nuclear
Medicine, University of the Witwatersrand, Johannesburg, South Africa. The
renal functional reserve represents the capacity of the kidney to increase
its level of operation under certain demands. The renal functional reserve
can he determined by measuring the change in inulin or creatinine
clearance following the ingestion of protein. The determination requires
the continuous infusion of inulin and PAl-I for at least 6 hours. An
increase of 20% in the glomerular filtration rate is regarded as normal
renal functional reserve. Aim: An alternative to this is proposed in which
the change in glomerular filtration rate [GFR (51Cr-EDTA clearance)1
and 99"Tc-MAG clearance is determined before and after the consump-
tion of a diet high in protein for up to 7 days. Methods: The patients (10)
selected for the study were potential renal donors undergoing routine
evaluation of renal function. Baseline GFR was determined by following
the clearance of 51Cr-EDTA from the blood by taking multiple blood
samples up to 210 minutes after injection. SsmTcMAG was injected
simultaneously and MAG clearance (approximately 2/3 of ERPF) was
determined simultaneously from the activity in the same blood samples.
The patients were requested to consume a diet high in protein (meat, fish)
for up to 7 days. The GFR and ssmTcMAG clearance was determined
again. Each determination was carried out in the morning following a light
(no meat), caffeine-free breakfast with the patient hydrated. Results are
shown in the table.
Table 1. Change in GFR and 99mTcMAG clearance following protein
loading
Patient N
GFR
ml/min
9smTe-MAG clearance
N ml/mina
Pre-protein loaded
Post-protein loaded
10
10
90.7 23.7
(47.8—129.4)
113.1 27.1
(74.8—158.3)
6
5
220.5 23.7
(185.2—264.7)
539.3 183.8
(324.7.-784.1)
% increasea 24.7 12.8
(12.9—55.0)
128 87
(44.6—269)
Data are mean SD (range)
Conclusions: (1) GFR increased by 12-55% following the consumption of
a diet high in protein, similar to literature values. (2) Increases in
SSmTcMAG clearance paralleled the increase in GFR, and this finding is
in keeping with a reported increase in PAH clearance following a protein
load. (3) The proposed method of determining the renal functional
reserve appears considerably simpler than the conventional inulin infu-
sion.
Geriatric CAPD in Johannesburg—Joys and jeopardy. KI. Furman and
AM. Meyers, Department of Medicine, Division of Nephrology, University of
the Witwatersrand and the Johannesburg Hospital, Johannesburg, South
Africa. From July 1979 to June 1994, a total of 89 patients over the age of
60 years were started on CAPD. Ages ranged from 60 to 82 years with a
mean of 64.7 years. Duration of treatment varied from 3 to 128 months,
with a mean of 27.2 months. Thirty-three (38%) of these patients were on
CAPD for less than 1 year and a further 17 (19%) for less than 2 years.
Twenty-two (25%) were on CAPD for more than 3 years and 13 (15%) for
over 5 years. The mortality rate was understandably high for this age
group. Forty-nine (55%) died while on CAPD, and 25 of these died within
the first year on CAPD, mostly due to co-morbid pathology that was either
unsuspected or considered to be stable and controlled at the start of
treatment. Five patients died from peritonitis. Eight patients were trans-
planted, six of whom died within 2 years post-transplantation. Thirteen
patients were transferred to hemodialysis because of repeated attacks of
peritonitis or inadequate ultrafiltration. All have since died, as did 7
patients in whom all treatment was withdrawn because of inability to cope
with the regimen. Six patients were transferred to other centers and were
lost to follow-up. In the remainder, CAPD was adequate and effective in
achieving a good measure of rehabilitation. Spouse and family support
played a major role in correcting errors of technique and instilling
confidence to these elderly patients who frequently became forgetful and
confused.
Nutritional assessment and adequacy of dialysis in CAPD patients. C.
Willett, M. Hollander, E. de Reuck, G. Fortuin, and B. Rayner, Renal Unit
and Department of Dietetics, Groote Schuur Hospital, Cape Town, South
Africa. Adequate nutrition and adequacy of dialysis are important deter-
minants of morbidity and mortality in CAPD patients. Our aim was to
prospectively study this in our CAPD population. All new CAPD patients,
who had not previously undergone long-term hemodialysis or renal
transplantation, were studied. At entry all patients had standard perito-
neal equilibration tests and 24 hour dialysate and urine collection to
calculate their weekly creatinine clearance, KT!V urea, and protein
nitrogen appearance (PNA). Additionally, trained dieticians (CW and
MH) did anthropometric measurements to calculate fat free mass, % body
fat and BMI, and took detailed dietary histories. These measurements
were all repeated at 6, 12 and 24 months. Only data are included of
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patients completing more than 6 months of follow-up. To date 7 patients
have been followed for 6 months and a further 6 for 12 months. There are
2 males and 10 females with a mean age of 52 years. Anthropometric data
tended to show a gain in body weight due to an increase in % body fat. Fat
free mass remained stable. Patients tended to decrease their energy intake
due to a reduction in carbohydrate intake. Most patients had adequate
weekly creatinine clearance, KT/V urea and PNA, but these declined with
time due to a reduction in residual renal function. There was good
correlation between KT/V urea, weekly creatinine clearance, and PNA.
The creatinine ratio at 4 hours correlated well with KT/V urea and
creatinine clearance. In summary, most CAPD patients following standard
dialysis prescriptions had no evidence of significant malnutrition, or
evidence of inadequate dialysis.
Assessing the adequacy of CAPD. GIL Latiff S. Naicker, YK Seedat,
and G. Ne!, Renal Unit, Addington Hospital, and Department of Medicine,
University of Nata4 Medical School, Durban, South Africa. Aims: (1) To
assess, using KT/V urea, whether our patients are being adequately
dialyzed. (2) To calculate, using urea kinetics, the protein catabolic rate
(PCR)—a measure of the dietary protein intake (DPI). (3) To determine
the peritoneal membrane permeability of these patients using a 4 hour
peritoneal equilibration test (PET). Methods: Twenty-five stable CAPD
patients were randomly selected. A KT/V urea of 1.7 per week was defined
as minimum acceptable therapy. A PCR of 1 g/kg!day was regarded as
adequate. Depending on the results of the PET, patients were divided into
4 categories according to high, high average, low average and low
transporters—according to the rate of transport of glucose and creatinine
(expressed as ratios) across the peritoneum. All calculations were done
using a computer-based kinetic modeling program for peritoneal dialysis(PD ADEQUEST). Results: Seventeen males and 8 females comprised
the study sample. Six (24%) patients had KT/V values of less than 1.7.
Fifteen (60%) patients had a PCR of less than 1 glkglday. Based on PET
results, 14 (56%) patients were "average" transporters, while 5 (20%) and
6 (24%) patients had high and low permeability membranes, respectively.
Conclusions: (1) 25% of our CAPD patients are being underdialyzed.
Quantitative assessments of the adequacy of dialysis need to be routinely
implemented, allowing for a prospective and objective approach to
dialysis. (2) Protein mulnutrition is a major problem in our unit, with 60%
of patients having a subnormal DPI. Urgent attention needs to be paid to
dietary counseling and adjustments of dialysis regimens. (3) Most patients
were "average" transporters and would be suitable for any form of
peritoneal dialysis. High and low transporters require special dialysis
prescriptions.
Bilharzia and renal failure in Natal. N.G. Christopher, J.C. Oviedo-
Pascottin4 S. Naicker, and KN. Rughubar, Department of Urology, Depart-
ment of Medicine, and Department of Pathology, University of Natal,
Durban, South Africa. Introduction: The current impression in South
Africa is that the bilharzia seen here differs from that in Central Africa
and Egypt. Progressive disease leading to renal failure has been reported
as rare by Powell et al (1968). Naude (1984) concluded that, "in Natal,
bilharzia of the ureter has been found to be surprisingly harmless". The
clinical impression is that these conclusions are no longer valid. Aim: (1)
A preliminary study to assess the number of patients treated with renal
failure and bilharzia. (2) To assess whether renal failure is due to
mechanical obstruction or due to glomerulonephritis as seen with Schis-
tosoma mansoni. Methods and materials: A prospective study between
July and December 1992. All patients with bilharzia and renal failure were
assessed. Patients with reflux were excluded. Patients' age, sex, full blood
Count, urea and electrolytes, creatinine, creatinine clearance, C3 + C4
complement, and immunoglobin were recorded. Renal and ureteric
specimens were sent for histology. Rectal biopsies were taken to exclude
S. mansoni. Results: In 1992, 15 patients with bilharzia were treated for
renal failure. Ages ranged from 5 to 36 years (mean 21 years). Male to
female ratio was 9:6. Africans to Indians ratio was 14:1. Seven patients
were studied, 11 renal biopsies/nephrectomy specimens were analyzed
from July—December 1992. Serum complement and immunoglobins were
normal in all. Rectal biopsies excluded S. mansoni. Renal histology
included tubular atrophy, periglomerular fibrosis, glomerular fibrosis,
chronic pyelonephritis, and interstitial nephritis. The ureters showed
fibrous replacement of smooth muscle. Discussion: Kruger (1990) has
shown that limited hybridization S. hematobium/S. mattheei does not
influence the virulence of the parental species as previously postulated in
South Africa. In this preliminary study, bilharzial ureteric strictures caused
renal failure by mechanical obstruction. This needs to be confirmed in a
larger series.
Prolonged survival of children with autosomal recessive polycystic
kidney disease (ARPKD) for more than 18 years. KE.C. Meyers and P.D.
Thomson, Division of Paediatric Nephrology, Department of Paediatrics,
University of the Witwatersrand and Johannesburg Hospital, Johannesburg,
South Africa. Aim: To assess the long-term survivors with ARPKD.
Method: A retrospective chart review of children at our institution
surviving for 18 years or more with ARPKD. Results: There were 9
patients for analysis, 5 of whom were male. Their ages ranged from 19.85
to 24.45 years. Three patients died at 19.85, 20.58, and 24.25 years,
respectively. Age range at diagnosis was 0.1 to 11.85 years (2.86 4.17).
Hepatic manifestations were central hepatomegaly and hepatic fibrosis
(9), splenomegaly with portal hypertension (7), porto-systemic shunt
procedure (5), gastro-esophageal varices (2), and splenectomy (2). One
patient had ascending cholangitis. Renal complications included, large
kidneys (9), hypertension (8), urinary infections (3), and native nephrec-
tomies (1). Time from diagnosis to onset of ESRF was 4.25 to 16.82 years
(10.99 4.62). Eight of nine patients were transplanted (TP). TP1 LRD =
3; TP CD = 5; TP All CD = 4. The pre-emptive transplant status was:
PD 0/8; HD 2/8; "off the floor" 6/8. Actuarial first graft survival was: 1 year
100% and 4 years 69%. Immunosuppression included: Pred/Aza (2/8);
Pred/Aza/CSA (5/8); plus TLI (1/8). Growth was generally better post-
transplant.
Pre-TP TP Post-TP
YEARS —3 —1 0 +1 +3
Mean VSDS —1.09 —1.21 —2.42 1.21 3.20
The three patients who died were complicated by hepatic encephalopathy,
variously raised ammonia levels, and normal synthetic function/enzymes.
Conclusions: The long-term prognosis for ARPKD is not as poor as
originally reported. Late liver decompensation is a problem. Because of
the latter, hepato-systemic shunting must be considered with circumspec-
tion, particularly if liver-renal transplantation is to be contemplated.
Further studies of ammonia handling by children with ARPKD are
needed.
A scoring system for evaluating patients for selection to a dialysis!
transplant program. M.L. GrtjJiths and C.F. Kewley, Renal Unit, Frere
Hospital, East London, South Africa. Aim: To assess the feasibility of a
point system to evaluate prospective dialysis and transplant candidates.
Methods: Using a questionnaire, points were allocated to patients with
chronic renal disease in 3 categories, according to: (1) Communication,
insight (ability to speak English, standard of education, availability of
telephone). (2) Access to the dialysis center (distance, transport). (3)
Socio-economic factors (employment, housing, support system). To test
the reliability of the scoring system, 20 previously accepted patients were
analyzed retrospectively. Results: Complete data were obtained in 99
patients. Sixty-five patients were aged 59 years or less. Of these, 34 (52%)
were in stable employment, 32 (49%) had completed primary school, and
40 (62%) were able to communicate in English, and 39 (60%) lived within
50 kilometers of the center. Associated diseases which could adversely
affect selection were present in 25 (38%). The most common was diabetes
(16 patients). With our limited resources ideal candidates were considered
to be 49 years or less, with stable employment, had passed Std 5, were able
to speak English and had no other serious disease. Only 17 patients of the
total sample (17%) met all these criteria, and 7 of these resided within 50
kilometers and the other 10 resided more than 50 kilometers from the
dialysis facility which would virtually exclude them. These two groups of
patients scored an average of 20 and 14.3, respectively. In the retrospective
analysis, a score of 17 or more predicted satisfactory compliance. Couclu-
sion: The scoring system predicts successful compliance on a dialysis and
transplant program. More than half (58%) of the ideal candidates lived
further than 50 kilometers from the hospital, and these areas require
separate dialysis facilities.
The correction of the anemia of chronic renal failure with recombinant
human erythropoietin (rHuEPO)—Stabilization and maintenance study.
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M.R. Moosa, C.R. Swanepoel, CL. Edeistein, and J. Jacobs, Renal Unit,
Tygerberg Hospital and the Department of Internal Medicine, University of
Stellenbosch, Cape Town, South Africa. Introduction and aims: Anemia,
which is present in 97% of patients on maintenance hemodialysis, can be
seriously debilitating. The major cause of the anemia is the failure of
eiythropoietin production by the diseased kidney. Recombinant human
eiythropoietin (rHuEPO) can produce a dose-related rise in the hemo-
globin level with an associated improvement in symptomatology related to
tissue hypoxia. The aim of this study was to determine the efficacy and
safety of a locally produced rHuEPO product (Repotin). Method: Patients
on hemodialysis who had hemoglobin levels of less than 8 g% and satisfied
all the inclusion criteria were entered into the study. Repotin was
administered at an initial dose of 25 lU/kg intravenously three times per
week. The dose was increased until a target Hb of 8 g/dl was reached. The
Repotin was then administered subcutaneously to maintain Hb levels of
9—10 g/dl. The patients were carefully monitored for any side-effects.
Results: Twenty-seven patients were successfully enrolled and followed-up
in the study. The mean Jib rose from 6.55 g/dl to 8.07 g/dl over a period
of 12 weeks. The mean dose of Repotin used was 63.4 lU/kg. In the
maintenance phase 55.5 lU/kg of Repotin was required to maintain the
target Hb between 9-10 gldl. A total of 46 adverse events was recorded in
21 patients. Only 15% were thought to be causally related to the
treatment. The most serious of these adverse events was the clotting of 3
fistulae. Conclusion: Repotin is an effective and safe rHuEPO product.
A low-dose strategy for erythropoietin (EPO) in a large dialysis unit.
A.A. Khan, R.F. Jeffrey, P. Prabhu, A.M Davison, and E.J. Will, St. James's
University Hospital, Leeds, England, United Kingdom. Aims: The optimum
strategy for EPO use in a large dialysis unit is undefined. We have
investigated the hypothesis that fixed low-dose subcutaneous (s.c.) EPO
would obviate the need for transfusion, and effect a favorable hematolog-
ical response, with minimal supervision. Methods: Twenty-five transfu-
sion-dependent adult dialysis patients (18 hemodialysis, 7 CAPD) received
a fixed dose of 1,000 units EPO thrice weekly. Monthly hematological
profiles and transfusion requirements before and after EPO treatment
were recorded. Patients were reviewed monthly and side-effects noted.
Duration of treatment ranged from 12—105 weeks (mean 59). Results:
Three patients did not respond to EPO because of chronic GI blood loss,
chronic sepsis, polyserositis, and Al toxicity. The remaining 22 responded
with an increase in Hb [6.86 0.9 g/dl (SD) to 9.06 1.18 g/dl (SD) after
3 months). Nine of the 22 patients achieved a Hb of 10 g/dl or more after
a mean of 18 weeks (range 8—52). Ninety-four u packed cells were
transfused to the 22 responders during the 3 month period to EPO
treatment and there were no transfusions during the first 3 months of
treatment. Mean BP did not change during treatment. Two patients
developed hypertension, one of whom clotted her fistula. Conclusions: In
the group where no EPO resistance factor was present, fixed low dose s.c.
EPO conveyed hematological benefit and, in view of a favorable side-effect
profile, would allow reduced medical review. This implies that a higher
proportion of patients in a large dialysis unit could be treated safely and
with benefit, than if an individual high-dose strategy were adopted.
Intravenous iron in hemodialysis patients. R. van Zyl-Smit and IA.
Halkett, Renal Unit Groote Schuur Hospital and Department of Medicine
University of Cape Town, South Africa. Iron supplementation is often
ineffective in correcting iron deficiency in hemodialysis patients. We
report the successful use of total dose iron infusion (TDI) of an iron
polymaltose complex in 59 patients with minimal adverse effects and a
gratifying therapeutic response. TDI was given to patients with a hemo-
globin of <10 gldl and a transferrin saturation of 20% or less. Despite
receiving 200 mg of ferrous sulphate after each dialysis, 36% of our
screened hemodialysis patients were iron deficient by these criteria with a
mean transferrin saturation of 11% and mean ferritin levels of 68 ng/ml.
Of these, 37% responded with a rise in hemoglobin of 2 gldl or greater [the
average rise being 3.16 g/dl, reaching a level of 9.8 gldl (range 6.9—13.7 su
1.88)]. A lower mean baseline hemoglobin prior to TDI was predictive of
a good response. There was no difference in baseline mean ferritin values
between responders and non-responders (66 vs. 71 ng/ml). Similarly, no
difference in mean baseline transferrin saturation was noted (10.9% vs.
12.1%). This study demonstrated the high frequency of iron deficiency,
despite oral supplementation, the use of transferrin saturation as a marker
of iron deficiency, and the safety and efficacy of the particular intravenous
iron preparation used.
Leukocyte analysis of tubulointerstitial nephritis in primary mesangio-
capillary glomerulonephritis (MCGN). 1.P. Naiker, R. Ramsaroop, S.
Somers, LG.H. Randeree, S. Naicker, and YK Seedat, Departments of
Medicine and Anatomical Pathology, University of Natal and Regional
Laborato,y Services, Durban, South Africa. The pathogenesis of tubuloin-
terstitial inflammation in relation to primary glomerular diseases is
uncertain. It may progress, however, perhaps due to cellular immune
mechanisms and may be the key to progression to chronic renal failure.
This study aims to characterize the mononuclear leukocytic interstitial
infiltrate in primary MCGN and correlates the degree and nature of
infiltrate with renal function methods. Cellular identification using mono-
clonal antibodies to leukocyte cell-surface antigens was conducted on
tissue from 17 patients with primary MCGN (Group I) and 10 controls
with non-proliferative GN (Group II); renal function was estimated at the
time of biopsy. Results: Group I showed significant increase in total
leukocytes (LCA), T lymphocytes (T), and B lymphocytes (B) compared
to Group II. Monocytes (1(P1) were not significantly increased. Cells/mm2
(Group I vs. Group II): LCA 1306 1254 versus 138 91 (P =0.0004);T638 547versus42 60(P = 0.005); B 161 165 versus 57 50(P =
0.02); and KP1 125 153 versus 54 59 (P = 0.17). In Group I, T cells
were dominant (that is, 48.8% of total, B 12.3%, and monocytes 9.5%). A
moderate correlation existed between LCA and impaired renal function:
serum creatinine (r = 0.43) and creatinine clearance (r = —0.41). This
correlation was strongest for T cells (r = 0.63) followed by KP1 (r = 0.46)
and B (r = 0.41). In conclusion, we have demonstrated a significant
mononuclear leukocytic interstitial infiltrate in primary MCGN and a
correlation between all cells of this infiltrate with impaired renal function.
This correlation was strongest for the most frequently observed cell, the T
lymphocyte.
Preliminary experience with FK 506 in renal allograft rejection. MID.
Cassidy, MD. Pascoe, ER. Irving, and D. Kahn, Department of Medicine
and Surgery, University of Cape Town and Groote Schuur Hospital, Cape
Town, South Africa. FK 506 is a potent immunosuppressive agent which
has similar actions and side-effects to cyclosporine A. Though structurally
dissimilar, they are both derived from a fungal source. Since February
1994 we have used FK 506 (Fujisawa GmbH) as rescue therapy on
compassionate grounds in 7 patients with steroid resistant acute renal
allograft rejection. The group consisted of 3 females and 4 males with a
mean age of 30 years (range 22—49); baseline immunosuppression con-
sisted of cyclosporine A, prednisone, and azathioprine. In 6 patients this
was the first graft. In 5 cases FK 506 was used as rescue therapy in the first
3 weeks after transplantation and in the other 2 cases at 9 and 53 months,
respectively. In all cases acute rejection was not controlled by pulse
solumedrol, 500 mg daily on three successive days. OKT3 was not used
due to fluid overload at the time of rejection in all cases. Acute severe
rejection was confirmed in all cases histologically. Rejection was reversed
in 6 of the seven patients, with a current mean serum creatinine 266
btmol/liter (range 141—419); 3 patients have a current serum creatinine of
< 200 mol/liter. Dialysis was stopped in the seventh patient for a short
period after commencing FK 506; however, adequate graft function was
not maintained and a graft nephrectomy was performed 1 month after
commencing treatment. No clinically significant side-effects were encoun-
tered. In conclusion, our preliminary experience with the use of FK 506
rescue therapy has been extremely encouraging in patients suffering from
steroid resistant acute allograft rejection.
Combination therapy with ketoconazole and cyclosporine in renal
transplantation. M. Pascoe, I Halkett, M. Cassidy, and D. Kahn, Renal
Unit, Groote Schuur Hospital, and Departments of Medicine and Surgery,
University of Cape Town, Cape Town, South Africa. The concomitant use of
CsA with ketoconazole (K) alters the metabolism of CsA such that lower
doses of CsA may be used to maintain therapeutic blood concentrations.
In the 3 year period up to December 1993, 32 renal allograft recipients
received combined cyclosporine and ketoconazole therapy (C/K), and a
group of 34 patients served as controls. The 2 groups were similar in age,
sex, and primary renal disease. The C/K group received combination
therapy for 12 months, while the control group received CsA for 6 months
and then prednisone/azathioprine only. Patients were followed from the
time of grafting to death, or until December 1993. The mean follow-up for
the C/K group was 22.5 10.2 months and for the controls was 32.9 18.5
months. C/K therapy was prematurely stopped in 4 patients, 1 because of
poor control of hypertension, 2 because of difficulty with control of CsA
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blood concentrations, and I at the patient's request. Death due to sepsis
occurred in 3 patients in the first 3 months post-transplantation, and 1
patient lost the graft 9 months post-transplant while on maintenance with
prednisone/azathioprine only. In the control group 5 patients died of a
variety of causes. Graft function was lost in eight patients a mean of 52
weeks post-transplant (range 1 day to 3 years). The renal function was not
different between the 2 groups 12 months post-renal transplant. The
combination of CsA with ketoconazole can be used as a cost effective
method for reducing immunosuppressive costs and making the benefits of
CsA available to patients at substantial cost savings.
Organ procurement in the Johannesburg area. L. Botha, M. Yeller, R.
Britz, and J.R. Botha, Clinic Holdings Limited and J.H.B. Transplant Unit,
South Africa. The number of the patients in end-stage renal failure has
reached dramatic proportions in South Africa. An increasing number of
cadaver donors is currently required to make renal transplantation
available to these patients. This retrospective study was undertaken to
investigate the (1) number of renal donors available, (2) their source, and
(3) the subsequent distribution of the procured kidneys in the Johannes-
burg area. In the 18 month period, January 1, 1993—June 30, 1994, 69 renal
cadaver donors were harvested in the Johannesburg area. All harvesting
and transplantation was performed by the Johannesburg hospital trans-
plantation surgical team. The median age of the donors was 21 years with
a range of 2 to 63 years, and the male/female ratio was 3:1. The causes of
death were: trauma (52), natural death (14), overdose (2), and carbon
monoxide poisoning. 1. The blood groups were, Gr-A: 24 patients; Gr-B:
9 patients; Gr-O: 3 patients; Gr-AB: 3 patients; and unknown in 2. Of the
69 donors, 34 (49%) were from the private sector and 35 (51%) were from
Johannesburg hospital. In the six months of 1994, there were 16 (64%)
donors from the private sector and 9 (36%) from the Johannesburg
hospital. During the period studied, 118 kidneys were transplanted in the
Johannesburg area, 10 (9%) in the private sector, and 101 (91%) at the
Johannesburg hospital. Conclusion: (1) There is an increasing number of
donors available in the private sector and a changing pattern of donor
availability in Johannesburg. (2) Close cooperation between the private
and public sector will be necessary to effectively utilize all potential donors
in the Johannesburg area.
Attitude toward organ donations and transplantations in the Eastern
Cape. V. Ramiah, D. Walker, T Maweni, and D. Kahn, Livingstone Hospital,
South Africa. Aim: To assess the attitude, awareness, and acceptability of
organ donation and transplantation among Xhosa speaking black patients
in the Eastern Cape. Method: One hundred thirty-five Black patients were
interviewed by a Xhosa speaking Sister in GOPD at Livingstone Hospital.
Results: Forty-eight percent of those interviewed had heart about brain
death. Only 18%, however, would accept that a family member was dead
if brain death was diagnosed; 95.5% had heard of organ donation and 62%
of patients interviewed would give consent to donation of family members'
solid organs. Only 35% of the total would give consent for donation of
eyes. A reported 78.5% of patients would have a transplant if they
required one; 81% would allow and advice a relative to have a transplant
if required. Only 15.5% would accept a transplant from an animal.
Conclusions: More than one-half of the study group were aware and
would consider organ donation. Transplantation is acceptable to the
majority of the group studied. Although the term brain death is familiar
with the majority, the actual concept is not properly understood. Educa-
tion of the community in order to dispel myths and fears cannot be
emphasized enough. There is a definite, strong resistance to xenografts.
Immunolocalization of atrial natriuretic peptide and tissue kallikrein
in the transplant kidney during acute rejection. D. Moodley, C. Snyman, S.
Naicker, R. Ramsaroop, and KD. Bhoola, Department of Experimental and
Clinical Pharmacology, Natal Medical School, Durban, South Africa. Atrial
natriuretic peptide (ANP), a hormone with natriuretic and diuretic
properties, plays a pivotal role in renal sodium and water homeostasis.
ANP has been immunolocalized in the intercalated cells of the connecting
tubules of the kidney and tissue kallikrein (TK) in the connecting tubule
cells, which is considered to increase vascular permeability through the
release of kinins. As yet there is no evidence as to which of these
proinfiammatory peptides are responsible for the vascular and cellular
damage observed during renal transplant rejection. Our study therefore
examines the spatial and cellular distribution of renal ANP and TK, in
normal and rejection states. Materials and methods: Renal biopsies from
patients with acute rejection, taken as a diagnostic procedure, were fixed
in 10% normal saline and embedded in paraffin wax. Normal kidney was
obtained from cadaver specimens. ANP and TK were immunolocalized
using antibodies specific to human ANP (1:100) and human TK (1:100).
The antibodies were preabsorbed with human IgG and human albumin (1
mg/mi) to reduce non-specific labelling. For the immunolabelling controls,
primary antisera were replaced with buffer or non-immune serum. Re-
sults: When compared to the normal renal tissue, ANP immunoreactivity
in the acutely rejecting transplant kidney was considerably depleted or
absent in the intercalated cells of the connecting tubule. Importantly, good
labelling results were obtained for TK in both the normal and rejecting
kidney. No labelling was observed in the method control sections.
Conclusion: ANP secretion in the acutely rejecting transplant kidney is
reduced, or even absent, when compared to the normal tissue. However,
no obvious reduction in the immunolabelling of TK was found. Our results
seem to indicate that ANP may be involved in the primary rejection
process. However, the question whether excessive formation of kinins
contributes to the rejection process remains unresolved.
An outbreak of nocardiosis in a renal transplant unit. G.H. Latiff S.
Naicker, YK Seedat, A.A. HaJfejee, and YM. Coovadia, Renal Unit,
Addington Hospital, and Departments of Medicine, Sweiy and Microbiol-
ogy, University of Natal, Medical School, Durban, South Africa. Aims: To
describe an outbreak of nocardia infection in our transplant unit. Meth-
ods: The medical records of 9 patients who acquired nocardiosis between
August 1991 and June 1993 were retrospectively reviewed. All were
recipients of first renal allografts. Results: The study sample was com-
prised of 6 males and 3 females (mean age = 40 years). Seven received
cadaver kidneys and the remaining 2 were living transplants. The mean
period between the date of the transplant and the onset of symptoms was
34 weeks. Symptoms were non-specific. All patients had pulmonary
disease. Eye disease with subsequent blindness and cutaneous involve-
ment (breast abscess) were seen in 2 patients, respectively. Radiological
features included cavitation, consolidation, and pleural effusions. Exami-
nation of sputa for typical branching filaments led to a diagnosis within 48
hours of admission. Diagnosis was subsequently confirmed by culture in all
patients. All patients were successfully treated with Co-Trimoxazole.
Attempts to isolate a hospital source of the infection were unsuccessful.
Conclusions: (1) A high index of clinical suspicion is essential for early
diagnosis. (2) Sputum examination was a reliable and quick method of
diagnosis. (3) It is unlikely that these patients acquired their infection in
the hospital.
Pregnancy after kidney transplantation. J. Kowalczylç A. Kobtyn, D.
Mahapa, and M. Marivate, Transplant Unit, Ga-Rankuwa Hospital, Pretoria,
South Africa. From January 1984 to December 1993, 98 kidney transplants
were performed at the Transplant Unit, Ga-Rankuwa Hospital. Thirty-
four recipients were female patients. Fifteen recipients of childbearing age
underwent the study. All 15 patients started to menstruate regularly after
kidney transplantation, and while on hemodialysis only 2 experienced
irregular menstrual bleeding. Five out of 15 patients planned pregnancy
after transplantation, and 2 of them successfully delivered healthy baby
boys. Two recipients had miscarriages and 1 experienced intrauterine fetal
death at 7 months of gestation. The first patient became pregnant 7 years
after a cadaveric kidney transplantation. Prior to pregnancy, her graft
function was stable with a serum creatinine of 98 jsmol/liter. The
immunosuppressive regimen consisted of azathioprine (Aza, 2 mg/kg body
wt) and low dose prednisolone (Pred, 0.2 mg/kg body wt). The second
patient became pregnant 6 years after a cadaveric kidney transplantation,
having a stable graft function and a serum creatinine of 120 mol/1iter.
She has been maintained on tripple immunosuppressive therapy with
cyclosporine A (8.5 mg/kg body wt), Aza (2.0 mg/kg body wt) and Pred (0.1
mg/kg body wt). Both babies were delivered by Caesarean section with an
Apgar score of 9. There were no congenital abnormalities found. At
pediatric follow-up the babies are well at 30 and 6 months post-delivery,
respectively. Conclusion: Kidney transplant offers a significant improve-
ment of quality of life to most chronic renal failure patients. A risk of
immunosuppression seems to have no major influence on the outcome of
pregnancy or child development.
Risk factors in acute renal failure—A prospective 5-year study (449
cases). CD. Potgieter, Division of Nephrology, University of Pretoria, Preto-
ria, South Africa. Aim: A prospective 5 year study evaluating several risk
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factors relating to the morbidity and mortality of acute renal failure.
Methods: Each case of acute renal failure referred to the renal service was
evaluated. The following factors were recorded: causes of acute renal
failure, initial urea, creatinine and electrolytes, blood pressure, fractional
sodium excretion, renal sizes, liver functions, time to recovery or death,
presence of oliguria or anuria, episodes of hypotension, cardiovascular
factors, respiratory factOrs, gastrointestinal factors, surgical factors, treat-
ment modalities, and outcomes. Results: Mortality was 63%. The
following risk factors were of major importance in influencing the
mortality: pneumonia, ventilation, hypotension, sepsis, diffuse intravascu-
lar coagulation, etc. Conclusions: Several factors influencing the survival
of patients with acute renal failure are important in evaluating patients
and in planning appropriate therapy. Risk factor analysis needs to be done
in each case to provide optimum therapy.
Allopurinol for calcium oxalate stones: The right drug for the wrong
reason? P.K Grover, V.R. Marshall, and R. Ryall, Department of Surgery,
Flinders Medical Centre, Bedford Park, South Australia, Australia. A critical
appraisal of the evidence commonly cited to support a link between high
urate excretion and calcium oxalate (CaOx) urinary calculi will be
presented. Analysis of relevant literature has revealed that this is based on
the clinical impression that stone formers tend to excrete more urate than
do healthy subjects and that administration of allopurinol reduces, albeit
slightly, recurrences of urinary calculi in patients with "hyperuricosuria."
Two theories have been invoked to provide a scientific explanation for
urate's apparently promotory effect. The first proposes that urinary orate
crystals promote CaOx precipitation by the phenomenon of epitaxy; the
second hypothesizes that particles of orate reduce the inhibitory activity of
urinary glycosaminoglycans which normally prevent the crystallization of
CaOx. However, to the present day, neither has been experimentally
verified. This has led to skepticism about the existence of a relationship
between a high urinary orate excretion and CaOx stone formation in
general, and the therapeutic use of allopurinol in particular. More recent
research from our group has revealed that at normal physiological pH
values, dissolved uratc directly promotes CaOx precipitation by the classic
"salting-out" effect by enhancing nucleation, growth, and aggregation of
CaOx crystals. Evidence linking urate excretion to CaOx urolithiasis will
be presented and discussed. It will be shown that the beneficial effect of
allopurinol can be attributed to its lowering the urinary output of orate
and thereby reducing the probability that CaOx will be salted out of urine,
rather than to epitaxy or inactivation of urinary glycosaminoglycans. Thus
allopurinol may, in fact, be the right drug for preventing stone recurrenc-
es—but for the wrong reason.
The Banif classification of renal transplant pathology: Clinicopatho-
logical correlation. R. Ramsaroop, S. Naicker, G.H. Latiff and A.A.
Haffejee, Regional Laboratory Services, and Renal Unit, Addington Hospital,
Durban, South Africa. Renal transplant biopsies are required for accurate
diagnosis and treatment of graft dysfunction, especially following the
utilization of cyclosporine (CsA) immunosuppressive regimens. The re-
porting of such biopsies has previously been subjective and the Banif
Working Classification of Kidney Transplant Pathology was recently
formulated as an international standard. This study is an audit of renal
transplant biopsies over a six year period, from July 1988 to June 1994,
reclassifying the histology according to the Banif Classification. Clinico-
pathological correlation relating histological severity to outcome is in-
cluded. A total of 176 biopsy and 20 nephrectomy specimens from 116
patients was reviewed. The histological categories included rejection (135)
and other pathology (29). Rejection was further categorized into acute
rejection (AR) (103)—Grade 1(60), 11(32) and III (11); chronic rejection(CR) (14)—Grade 1(12) and Grade III (2). Twenty of the AR fell into a
borderline category, where the histologic changes were patchy and early,
and 2 showed hyperacute rejection. Other pathology included: CsA
toxicity (4), acute pyelonephritis (3), interstitial nephritis (6), and acute
tubular necrosis (6). Graft loss was recorded in 30 patients, the most
frequent reason being infarction following acute vascular rejection (12).
Other reasons included: CR (6), progressive AR (4), recurrent glomeru-
lonephritis (2), and severe pyelonephritis (2). Most of the patients (58)
with stable renal function showed borderline to Grade I AR, with only 2
with evidence of CR. Patients with gradual deterioration in renal function
totalled 10, with 6 showing a progression from acute to chronic rejection
on biopsy and 4 showing mild acute rejection with concomitant severe
interstitial nephritis. Conclusions: (1) We have found that the Banif
Working Classification has promoted standardization of histologic criteria
in allograft biopsies. (2) It may serve as a guide to therapy. (3) There was
good correlation between histologic severity and clinical outcome.
Effect of urinary prothrombin fragment 1 on calcium oxalate crystalli-
zation in undiluted human urine. R.L. Ryall, P.K Grover, A.MF. Staple-
ton, Y. Tang, R. Moritz, and RI Simpson, Department of Suige,y, Flinder
Medical Centre SA, and Ludwig Institute for Cancer Research, Victoria,
Australia. Urinary prothrombin fragment 1 (Fl) is the predominant
protein incorporated into calcium oxalate (CaOx) crystals precipitated
from human urine. The aim of this study was to examine the effect of pure
Fl and CaOx crystallization in undiluted human urine. CaOx crystals were
generated in urine obtained from healthy men, by the addition of oxalate,
and demineralized with EDTA. The resulting extract was then desalted
and purified by reversed phase liquid chromatography on a Brownlee
RP-300 microbore column. Additional 24 hour urine samples were
collected from healthy men, pooled, centrifuged (10,000 X g) and 0.22
filtered (0.22 j.tm). A portion was retained as control (c) and the
remainder was ultrafiltered (10 kD; UF) and divided into aliquots to which
was added Fl at final concentrations of 0, 1.25, 2.5 and 10 mg/liter. CaOx
crystallization was then induced in each sample by the addition of oxalate,
followed by incubation with shaking for 2 hours at 37°C. The size and
volume of the particles deposited were determined using a Coulter
Counter and the crystals were examined by scanning electron microscopy
(SEM). CaOx precipitation was also determined in parallel experiments by
14C-oxalate deposition. The amount of oxalate required to induce crys-
tallization was identical in all samples, but the volume of particulate
material deposited increased in a dose-dependent manner from 8,154
m3/.d in UF urine to 16,814 xm3/td in the UF urine containing 10
mg/liter of Fl. The highest volume, 23,450 sm3/.rl, was recorded in the C
urine. However, the mean particle size decreased in reverse order from
18.3 m in the UF to 7.266 sm in the UF + 10 mg/liter urine, and 8.462
m in the C urine. This decrease in size was confirmed by SEM, which
showed that it was the result of a reduction in crystal aggregation rather
than in the size of individual crystals. Analysis of 14C-oxalate data
revealed a dose-dependent decrease in CaOx deposition with an increase
in Fl concentration, indicating that the increase in particle volume
recorded by the Coulter Counter resulted from inclusion of Fl into the
crystalline architecture, rather than increased deposition of CaOx. It was
concluded that Fl is the most potent macromolecular inhibitor of CaOx
crystal growth and aggregation in undiluted urine yet detected, and may
therefore be an important macromolecular determinant of stone forma-
tion.
Minimal change nephrotic syndrome (MCNS)—A 12½ year review at
Baragwanath Hospital. UK Kala and D. W.C. Jacobs, Department of
Paediatrics, Baragvanath Hospital, University of the Witwatersrand, Jo/ian-
nesbug, South Africa. Aim: To analyze the incidence and response to
therapy in black African children at Baragwanath Hospital from July 1981
to December 1993. Methods: A retrospective analysis of all patients with
biopsy proven MCNS with respect to age of presentation, sex, microscopic
hematuria, hypertension, response to steroids and cyclophosphamide, the
need for a second biopsy and incidence of pulmonary tuberculosis and
renal failure. Results: MCNS form 23.9% (82) of all nephrotics. Mean age
of presentation was 6.1 years (range 1.25—11.9 years). Male:female ratio
was 2.2:1. Incidence of microscopic hematuria was 84.1% (69). Initial
hypertension occurred in 13.4% (11); 2.4% (2) had steroid related
hypertension and 4.9% (4) had hypertension requiring therapy. Of 96
biopsies, 81 were initial, 15 (18.3%) repeat, and 2 post-mortem biopsies.
Of the repeat biopsies 8 had focal glomerulosclerosis, 6 remained MCNS,
and one was familial, 2.4% (2) had acute renal failure at presentation and
2.4% (2) developed chronic renal failure. Spontaneous remission in
(6.1%), 5 steroid responsiveness initially in (68%) 56, partial response in
(6.1%) 5 and non-responsiveness in (13.4%) 11. Frequent relapses
occurred in (25%) 14 of initial responders and of 12 treated with
cyclophosphamide 7 responded. TB occurred in 11% (9). The mortality
was 4.9% (4). Thirty-eight patients have been lost to follow-up. Conclu-
sion: MCNS accounts for 25% of the total nephrotics under 12 years.
There is a high incidence of microscopic hematuria at presentation. Initial
response to steroids conforms to that reported internationally.
